Investigating how certain toxins trigger autoimmune responses in the central nervous system.
Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon Toxin
This study is looking into why some people get Multiple Sclerosis (MS) while others don’t, even if they have similar genes, by exploring how certain toxins might affect the immune system and the brain, with the hope of finding new ways to diagnose and treat MS.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11088204 on NIH RePORTER |
What this research studies
This research aims to understand why some individuals develop Multiple Sclerosis (MS) while others with similar genetic predispositions do not. It focuses on the role of environmental triggers, specifically the toxins from Clostridium perfringens and Bordetella pertussis, in breaking down the immune barriers of the central nervous system. By studying how these toxins affect immune responses and the behavior of specific immune cells, the research seeks to identify new diagnostic tools and potential therapeutic targets for MS. The approach includes using animal models to observe the effects of these toxins on the immune system and the central nervous system.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a genetic predisposition to Multiple Sclerosis or those experiencing early symptoms of the disease.
Not a fit: Patients who do not have a genetic risk for Multiple Sclerosis or are not experiencing any autoimmune symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new diagnostic methods and treatments for Multiple Sclerosis.
How similar studies have performed: Previous research has shown promise in understanding autoimmune responses through similar mechanisms, but this specific approach is relatively novel.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Vartanian, Timothy — Weill Medical Coll of Cornell Univ
- Study coordinator: Vartanian, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.